Browsing: Gastrointestinal

A Chinese phase 2-3 trial of 178 patients with resectable intrahepatic cholangiocarcinoma demonstrates neoadjuvant GOLP (gemcitabine–oxaliplatin + lenvatinib + toripalimab)…

The PROSPECT trial found that neoadjuvant FOLFOX alone resulted in similar survival and disease control outcomes compared to chemoradiation for…

Top Line: For locally-advanced esophageal squamous cell carcinoma (SCC), is understanding upfront surgical pathology versus pathologic response to neoadjuvant chemoradiation…

Top Line: Does the addition of immunotherapy improve response rates to standard neoadjuvant therapy for locally advanced rectal cancer?The Study:…

Top Line: A recent pooled analysis suggests external beam radiation provides the best non-surgical disease control of hepatocellular carcinoma (HCC).The…

We’ve long known exercise is good medicine during and after cancer treatment, but CHALLENGE provided cold hard facts to bolster…

In the OPRA trial, 74% of rectal cancer patients had a complete or near-complete response to total neoadjuvant therapy and…